The obesity epidemic is vast. The solutions are emerging. Science is evolving. And the market is expanding. The launch of Yurpeak is another step in ... Dec 12
As more women use these medications globally and as research expands, the world will gain a clearer picture of how these powerful drugs shape reproductive ... Nov 26
As the patent clock ticks towards 2026, both Novo and Lilly are likely to intensify their efforts in expanding supply chains, boosting physician engagement, and ... Nov 14
Long-term effects of GLP-1 medications remain under investigation, and shifting to easy-to-use pens removes barriers but not risks.... Aug 16
Generic semaglutide could ultimately become not just an alternative, but the new standard driven by precision manufacturing, scaled access, and cost redefined.... Aug 11
India is stepping into a new phase of healthcare where the battle against obesity is no longer limited to gym memberships or diet fads.... Aug 01
As India confronts an alarming rise in obesity and related conditions like type 2 diabetes, cardiovascular disease, and polycystic ovarian syndrome, the spotlight on medical ... Jun 25
... May 12
A somewhat promising era of weight management has arrived. Ozempic and Mounjaro are no longer just for diabetes. But it’s not all magic. Risks, ... May 10
The WHO's endorsement of GLP-1 receptor agonists represents a significant development in the global fight against obesity.... May 08
The next time you reach for that bag of chips or can of soda, remember: whats easy today may be costly tomorrow. Choose wisely.... Dec 06
Many weight management solutions available today ultimately fail partly because patients do not receive the help they need, when they need it.... Jun 20
In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market ... May 13
Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ... Apr 20
Celebrities vouch for them, but weight loss drugs like Wegovy, Ozempic, Saxenda, and Victoza pose serious digestive risks. Recent research reveals the downside, shedding light ... Oct 07
FDA approves Wegovy injection which is a chronic weight management drug. This can be used in patients who are overweight and suffering from high blood ... Jun 11
-Advertisements-
.jpeg)
Thursday, October 08, 2026
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)